Evolus EOLS
NASDAQ EOLS
$8.39 +0.04 (+0.48%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evolus (EOLS) Cash & Current Investments (2018 - 2026)

Evolus' (EOLS) quarterly Cash & Current Investments came in at $49.8 million in Q1 2026, down 26.66% YoY from $67.9 million in Q1 2025, and down 7.49% on a QoQ basis from $53.8 million in Q4 2025.

Evolus (EOLS) Cash & Current Investments (2018 - 2026) Analysis & Trends

Evolus (EOLS) has 9 years of Cash & Current Investments data on file, last reported at $49.8 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 26.66% year-over-year to $49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.8 million (down 26.66% YoY) and the FY2025 annual result came in at $53.8 million, down 38.1% from the prior year.
  • Cash & Current Investments slipped to $49.8 million in Q1 2026, from $53.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $106.7 million in Q1 2022 to a low of $31.5 million in Q1 2023.
  • A 5-year average of $66.2 million and a median of $62.8 million in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 381.13% — and 2023, when it plunged 70.5%.
  • Tracing EOLS's Cash & Current Investments over 5 years: stood at $53.9 million in 2022, then advanced by 16.53% to $62.8 million in 2023, then surged by 38.37% to $87.0 million in 2024, then plunged by 38.1% to $53.8 million in 2025, then retreated by 7.49% to $49.8 million in 2026.
  • The last three Cash & Current Investments figures came in at $49.8 million (Q1 2026), $53.8 million (Q4 2025), and $43.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 963.33 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 3.66 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 1.68 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 5.80 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 2.66 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 886.50 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 389.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 530.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 164.00 Mn
10 Evolus 552.49 Mn 507.32 Mn 57.18 Mn 45.17 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 45.17 Mn
Mar 31, 2026 49.79 Mn
Dec 31, 2025 53.83 Mn
Sep 30, 2025 43.52 Mn
Jun 30, 2025 61.74 Mn
Mar 31, 2025 67.89 Mn
Dec 31, 2024 86.95 Mn
Sep 30, 2024 85.04 Mn
Jun 30, 2024 93.67 Mn
Mar 31, 2024 96.96 Mn
Dec 31, 2023 62.84 Mn
Sep 30, 2023 38.69 Mn
Jun 30, 2023 41.71 Mn
Mar 31, 2023 31.46 Mn
Dec 31, 2022 53.92 Mn
Sep 30, 2022 65.57 Mn
Jun 30, 2022 84.48 Mn
Mar 31, 2022 106.67 Mn
Dec 31, 2021 146.26 Mn
Sep 30, 2021 107.80 Mn